⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19747589 | 0.81 | CSNK1D (0.38) | — | |
| SCHEMBL23547562 | 0.78 | HAVCR2 (0.33) | — | |
| SCHEMBL24490808 | 0.63 | MAPT (0.35) | — | |
| SCHEMBL22569900 | 0.60 | PIK3CG (0.33) | — | |
| SCHEMBL19748312 | 0.60 | ALDH1A1 (0.35) | — | |
| SCHEMBL19748127 | 0.60 | CSNK1D (0.31) | — | |
| SCHEMBL25214068 | 0.60 | GAA (0.35) | — | |
| SCHEMBL23631073 | 0.59 | — | — | |
| SCHEMBL3013268 | 0.59 | KMT2A (0.35) | — | |
| 5-Bromouracil SCHEMBL8740942 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230033360-A1 | COMPOUNDS AS CD73 INHIBITORS | BIOARDIS LLC | 2023-02-02 | — | — | US | disclosed |
| EP-4055026-A1 | COMPOUNDS AS CD73 INHIBITORS | Bioardis LLC (US) | 2022-09-14 | — | — | EP | disclosed |
| CN-114945578-A | Compounds as CD73 inhibitors | 博奥阿迪斯生物科技公司 | 2022-08-26 | — | — | CN | disclosed |
| US-20220204539-A1 | CD73 INHIBITORS | BIOARDIS LLC | 2022-06-30 | — | — | US | disclosed |
| CN-114286824-A | CD73 inhibitor | 博奥阿迪斯生物科技公司 | 2022-04-05 | — | — | CN | disclosed |
| EP-3956341-A1 | CD73 INHIBITORS | Bioardis LLC (US) | 2022-02-23 | — | — | EP | disclosed |
| WO-2020210970-A1 | IMIDAZOTRIAZINE DERIVATIVES AS CD73 INHIBITORS | BIOARDIS LLC (US) | 2020-10-22 | — | — | WO | disclosed |